Bode John B
SEC insider (Form 3/4/5 filer). CIK 0001612084. Director at SPAR Group, Inc. (SGRP) and 3 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on Sep 29, 2026. Located in CHARLOTTE, NC.
Companies Bode John B has filed insider reports for
- SPAR Group, Inc. (SGRP): Director
- Stewards, Inc. (SWRD): Director
- ZEVRA THERAPEUTICS, INC. (ZVRA): Director
- Newton Golf Company, Inc. (NWTG): Director
Bode John B
CIK: 0001612084
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Sep 29, 2026SGRP
SPAR Group, Inc.
AwardDirect110K shares- - Mar 24, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
ExerciseDirect39.2K shares at avg. $4.97$195K - Mar 24, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
ExerciseDirect39.2K shares at avg. $4.89$192K - Jan 30, 2026NWTG
Newton Golf Company, Inc.
AwardDirect18.5K shares- - Aug 19, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
PurchaseDirect5K shares at avg. $9.16$46K - May 29, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
30K shares- - Mar 19, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
PurchaseDirect10K shares at avg. $7.96$80K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 29, 2026 |  SGRP SPAR Group, Inc. | Award | 110,000 | - | $0 | Direct |
| Mar 24, 2026 |  ZVRA ZEVRA THERAPEUTICS, INC. | Exercise | 39,200 | $4.97 | $194,824 | Direct |
| Mar 24, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Exercise | 39,200 | $4.89 | $191,688 | Direct |
| Jan 30, 2026 |  NWTG Newton Golf Company, Inc. | Award | 18,549 | - | $0 | Direct |
| Aug 19, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Purchase | 5,000 | $9.16 | $45,825 | Direct |
| May 29, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| Mar 19, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Purchase | 10,000 | $7.96 | $79,624 | Direct |
1-7 of 7 transactions